Patents by Inventor Allison KIRK

Allison KIRK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T-cell receptor for treating fibrolamellar hepatocellular carcinoma
    Patent number: 12528853
    Abstract: A vector harboring nucleic acids encoding a recombinant T cell receptor having antigenic specificity for a DnaJ heat shock protein family member B1-protein kinase cAMP-activated catalytic subunit alpha (DNAJB1-PRKACA) fusion protein is provided, as are host cells and a method for treating fibrolamellar hepatocellular carcinoma with the vector.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: January 20, 2026
    Assignees: St. Jude Children's Research Hospital, Inc., University of Maryland, Baltimore
    Inventors: Paul Thomas, Jeremy Crawford, Allison Kirk, Anthony Zamora, Scott E. Strome
  • T-Cell Receptor for Treating Fibrolamellar Hepatocellular Carcinoma
    Publication number: 20220251167
    Abstract: A vector harboring nucleic acids encoding a recombinant T cell receptor having antigenic specificity for a DnaJ heat shock protein family member B1-protein kinase cAMP-activated catalytic subunit alpha (DNAJB1-PRKACA) fusion protein is provided, as are host cells and a method for treating fibrolamellar hepatocellular carcinoma with the vector.
    Type: Application
    Filed: June 19, 2020
    Publication date: August 11, 2022
    Inventors: Paul THOMAS, Jeremy CRAWFORD, Allison KIRK, Anthony ZAMORA, Scott E. STROME